The prevalence of food allergy has increased significantly over the years. In the U.S., United Kingdom, Canada and Australia, food allergies affect up to 8% of children and up to 5% of adults. Peanut allergy alone affects up to 5% of infants and young children. What is driving this epidemic is unclear, but there is […]
New Allergy Emoji being considered
A campaign is underway to get an allergy emoji approved by the Unico Consortium. Unico approves all texts and emoji’s for use. A petition has been submitted on change.org and it is currently gathering signatures. Change.org The makers of Reactine Canada (generic name ceterizine) are behind the campaign for the allergy emoji. Antihistamines are commonly […]
Allergy to Marijuana
Allergy to marijuana has been on the rise with the legalization of medical marijuana and recreational marijuana in certain states. Here in California, recreational marijuana has become legalized on January 1st, 2018. Medical marijuana has been legal for more than 20 years but now with the full legalization in California, there will be more reactions […]
NHL Hockey Star, Marian Hossa Retiring Because of Allergy
Marian Hossa, an NHL winger for the Chicago Blackhawks will miss the upcoming season due to an allergy reaction to his hockey equipment. He has stated that he has developed severe side effects from the medication to treat his skin disorder. “While I am disappointed that I will not be able to play, I have […]
Odactra Sublingual House Dust Mite Allergen Approved by FDA
Odactra the first sublingual house dust mite allergen, has been approved by the FDA. Odactra will be administered under the tongue and it is used to treat house dust mite induced perennial allergic rhinitis and/or allergic conjunctivitis for adults 18-65 years of age. House dust mite is one of the most common perennial aeroallergens affecting […]
Xyzal OTC to be available March 2017
Xyzal OTC will soon be available without a prescription March 2017. In a growing trend in the allergy pharmaceutical market, most prescription medications are now becoming over the counter. Xyzal (generic brand name is levoceterizine) received FDA approval earlier this month for treatment for the relief of symptoms of seasonal and year round allergies. The […]
New California Epinephrine Law for 2017
In 2017, a new California Epinephrine Law went into effect. Businesses and public agencies in California are now defined as “authorized entities, are allowed to keep epinephrine auto injectors on hand to help treat emergency allergic reactions.”. Liability and professional review protections remain in place for physicians issuing a prescription or order for epinephrine auto […]
AllergyLosAngeles.com named Top Allergy Blog
We are proud to announce that our blog, was named one of the top 10 allergy blogs in the world by feedspot.com Top Allergy Blogs The list was based on quality of articles, quality and consistency of posts, social media influence and Feedspot’s editorial team and expert review. Being picked as a top allergy blog […]
New Peanut Guidelines
New peanut guidelines have been officially introduced by the National Institute of Allergy and Infectious Diseases in response to the earlier studies we have discussed from the LEAP trials. Peanut Allergy Prevention Peanut allergy is a growing public health problem. In the United States, peanut allergy prevalence is approximately 2% among children. Peanut allergy is […]
Auvi-Q to return to market
Auvi-Q is set to return to the market February 14, 2017. Auvi-Q was withdrawn off the market in the past because improper dosing and later it was sold to Kaleo. Auvi-Q Recall Many were wondering if Auvi-Q would ever return to the market again. Many patients liked the small packaging and the fact that it […]
- 1
- 2
- 3
- 4
- Next Page »